Fine Foods & Pharmaceuticals N T M S p A : TREASURY SHARES BUYBACK INFORMATION - 30 JANUARY – 3 FEBRUARY 2023 PERIOD

TREASURY SHARES BUYBACK INFORMATION

30 JANUARY - 3 FEBRUARY 2023 PERIOD

Verdellino (BG), 6 February 2023

Fine Foods & Pharmaceuticals N.T.M. S.p.A. as part of its treasury share buyback programme (the Programme) - which was launched on 13 May 2022 implementing the 10 May 2022 Shareholders' Meeting resolution - in the 30 JANUARY - 3 FEBRUARY 2023 period, purchased 846 treasury shares, (equal to 0.0033% of the share capital), at an average weighted price of € 8.1831, for a total value of € 6,922.92.

The buyback was made through the intermediary Banca Akros, LEI Code 549300GRXFI7D6PNEA68.

Below are the daily details of the buyback of Fine Foods & Pharmaceuticals N.T.M. S.p.A. ordinary shares, ISIN code IT0005215329, and the attached details of the transactions carried out during the above period

Date	Market	Purchase-	No. Of	Qty	Currency	Price	Total
Name	Sale	Transactions
31/01/2023	MTA	P	4	600	EUR	8.1926	4,915.56
01/02/2023	MTA	P	3	246	EUR	8.1600	2,007.36

Following the buyback outlined in this press release, the Company holds 1,026,611 treasury shares, representing 4.0165% of the share capital, as of 3 February 2023.

More detail below

***

This press release is available on the Fine Foods website www.finefoods.it,in the Investor Relations/Press Releases section.

Fine Foods & Pharmaceuticals N.T.M. S.p.A.
Via Berlino, 39 Zingonia-Verdellino 24040 (BG) Italia	CF / P.IVA IT 09320600969
T. [phone] [e-mail]	CAP. SOC. € 22.770.445,02

***

Fine Foods & Pharmaceuticals N.T.M. S.p.A., listed on Borsa Italiana's Euronext STAR Milan (Ticker: FF) is an Italian independent CDMO (Contract Development and Manufacturing Organisation) that develops and manufactures contract products for the pharmaceutical, nutraceutical, cosmetics, biocides and medical devices industries. Founded in 1984, Fine Foods proved to be a reliable and capable strategic partner for customers in the reference sectors. The company's organisation can provide successful design process and solid, long-term partnerships. The continuous search for excellence is part of the company's business model and includes research and development, innovation, process reliability, product quality, ESG, and sustainable management of the Group's supply chain. Fine Foods is a benefit corporation which relies on certifications and ratings under international standards. These guarantee its sustainability commitment across the business. With € 193 million revenue in 2021 and more than an 11 per cent CAGR over the last decade, Fine Foods is a growing and future-oriented company.

***

For further information:

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Tel [phone]

Investor Relations: [e-mail]

Media Relations: [e-mail]

Fine Foods & Pharmaceuticals N.T.M. S.p.A.
Via Berlino, 39 Zingonia-Verdellino 24040 (BG) Italia	CF / P.IVA IT 09320600969
T. [phone] [e-mail]	CAP. SOC. € 22.770.445,02

ATTACHMENT

Date	Market	Purchase-	Trade	Q.ty	Value	Price	Total
Sell	Time
31/01/2023	MTAA	P	09:18:55	200	EUR	8,2	1640
31/01/2023	MTAA	P	10:23:49	74	EUR	8,14	602,36
31/01/2023	MTAA	P	16:27:26	126	EUR	8,2	1033,2
31/01/2023	MTAA	P	17:07:03	200	EUR	8,2	1640
01/02/2023	MTAA	P	09:45:45	90	EUR	8,16	734,4
01/02/2023	MTAA	P	10:04:31	32	EUR	8,16	261,12
01/02/2023	MTAA	P	10:06:41	124	EUR	8,16	1011,84

Fine Foods & Pharmaceuticals N.T.M. S.p.A.
Via Berlino, 39 Zingonia-Verdellino 24040 (BG) Italia	CF / P.IVA IT 09320600969
T. [phone] [e-mail]	CAP. SOC. € 22.770.445,02